NCT04595357 is a clinical trial of Iris shelf technique in Eye Injuries, sponsored by Assiut University.

Who is sponsoring NCT04595357?

NCT04595357 is sponsored by Assiut University.

What drugs are being tested in NCT04595357?

Interventions in NCT04595357: Iris shelf technique.

What condition does NCT04595357 study?

NCT04595357 studies Eye Injuries.

Is NCT04595357 still recruiting?

NCT04595357 is currently completed. Last updated 20 October 2020.

Last reviewed 2020-10-20 · How we verify

NCT04595357

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

"Iris Shelf" Technique for Intraocular Foreign Bodies Removal

Completed Last updated 20 October 2020

What this trial tests

trial testing Iris shelf technique in Eye Injuries in 33 participants. Completed in 1 July 2020.

Timeline

1 January 2016

Primary endpoint
31 December 2019

1 July 2020

Quick facts

Lead sponsor	Assiut University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	33
Start date	1 January 2016
Primary completion	31 December 2019
Estimated completion	1 July 2020

Drugs / interventions tested

Iris shelf technique

Conditions studied

Eye Injuries — all drugs for Eye Injuries →

Sponsor

Assiut University

Who can join

Adults 15 to 45, any sex, with Eye Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intraocular foreign body (IOFB) injury is a common potentially serious form of ocular trauma. Metallic IOFB is the most common type of IOFB injury. Apart from the associated ocular tissue damage, Metallic IOFB may cause permanent visual impairment due to retinal toxicity and endophthalmitis. When presenting posteriorly, the approach of IOFB removal is challenging. Several techniques had been described for posterior IOFB removal. All of these techniques aimed to remove IOFB with the least possible collateral damage. This study aims to describe "Iris shelf" technique for posterior IOFB removal through a clear corneal incision combined with phaco-vitrectomy and report its outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04595357 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 20 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04595357.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing